NEWS & PRESS

Nov 5, 2012 - Entering First Patients into Phase I protocol
Oct 25, 2012 - New Process Development Laboratory at HCAR
Aug 2, 2012 - Immunomic Therapeutics Receives Notice of Patent Allowance For Chimeric Vaccines, a Core Component of LAMP-Vax™ Vaccines
May 24, 2012 - Immunomic Therapeutics’ CEO, Dr. William G. Hearl, to Present at the 2012 BIO International Convention in June
May 2, 2012 - Immunomic Therapeutics Receives IND Authorization for Phase I Study of JRCLAMP- Vax Vaccine to Treat Japanese Red Cedar (Sugi) Allergy
May 2, 2012 - Immunomic Therapeutics Receives IND Authorization for Phase I Study of JRCLAMP- Vax Vaccine to Treat Japanese Red Cedar (Sugi) Allergy in JAPANESE
March 26, 2012 - Filing of IND for JRC-LAMP-vax
Jan 9, 2012 - Iti Secures Phase I Funding For Japanese Red Cedar Lamp Vaccine
Jan 1, 2012 - LAMP Technology Promises Next Generation Vaccines to Improving Human Health
Apr 1, 2011 - Immunomic Therapeutics Shareholders Elect Board, Barry McDonald as Chair.

COMPANY
TECHNOLOGY
CLINICAL
MEDIA
Immunomic Therapeutics, Inc.
Headquarters: 1214 Research Blvd, Suite 201, Hershey, PA 17036
Phone: 717-327-1919
Lab: 15010 Broschart Rd. Ste. 110, Rockville, MD 20850
Phone: 866-515-9484

© 2007-2013 Immunomic Therapeutics, Inc.
All rights reserved